17 O QC and CS tensors were experimentally determined for the seven oxygen sites in salicylic acid and Aspirin. Although both salicylic acid and Aspirin form hydrogen bonded cyclic dimers in the solid state, we found that the potential curves for the concerted double proton transfer in these two compounds are significantly different. In particular, while the double-well potential curve in Aspirin is nearly symmetrical, it is highly asymmetrical in salicylic acid. This difference results in quite different temperature dependencies in 17 O MAS spectra of the two compounds. A careful analysis of variabletemperature 17 O MAS NMR spectra of Aspirin allowed us to obtain the energy asymmetry (ΔE) of the double-well potential, ΔE = 3.0 ± 0.5 kJ/mol. We were also able to determine a lower limit of ΔE for salicylic acid, ΔE > 10 kJ/mol. These asymmetrical features in potential energy curves were confirmed by plane-wave DFT computations, which yielded ΔE = 3.7 and 17.8 kJ/mol for Aspirin and salicylic acid, respectively. To complement the solid-state 17 O NMR data, we also obtained solid-state 1 H and 13 C NMR spectra for salicylic acid and Aspirin. Using experimental NMR parameters obtained for all magnetic nuclei present in salicylic acid and Aspirin, we found that plane-wave DFT computations can produce highly accurate NMR parameters in welldefined crystalline organic compounds.
INTRODUCTION
There has been an increasing interest in recent years to extend the realm of solid-state 17 O (I = 5/2) NMR spectroscopy to studies of a wide range of molecular systems from inorganic materials 1,2 to organic and biological molecules. 3−5 Compared to the routine use of 1 H, 13 C, 15 N, and 31 P NMR techniques that rely on detection of spin-1/2 nuclei, quadrupolar 17 O NMR is far less common, despite the importance and ubiquity of oxygen-containing functional groups in chemical compounds. Since the only NMR-active oxygen isotope, 17 O, has an exceedingly low natural abundance of 0.037%, a prerequisite of 17 O NMR studies of large biomolecules is to introduce the 17 O isotope into the functional group of interest. Another challenge in 17 O NMR is to deal with the intrinsic sensitivity and resolution limitations of detecting a half-integer quadrupolar nucleus. In particular, one can usually detect only the central transition (CT) in 17 O NMR studies of solids. For a spin-5/2 nucleus such as 17 O, the maximum CT intensity generated by a single selective RF pulse is only 8.6% of the total signal intensity, thus giving rise to a low intrinsic sensitivity in CT-based experiments. Furthermore, the second-order quadrupolar broadening of the CT cannot be completely removed by the magic-angle spinning (MAS) technique and, as such, imposes a limitation on the resolving power of this most commonly used solid-state 17 O NMR technique. For liquid samples, molecular tumbling often causes rapid quadrupole relaxation that leads to rather broad lines in 17 O NMR spectra. These limitations have so far set some boundaries for chemical and biological applications of 17 O NMR. A general approach to overcome these difficulties is to perform 17 O NMR experiments on highly 17 O-enriched samples at the highest magnetic field available. For example, we demonstrated that it is possible to obtain 17 O CT NMR spectra for large protein−ligand complexes (e.g., 80−240 kDa) in both solid and solution states at 21.1 T. 6−8 Another new emerging trend is to utilize 17 O NMR to obtain information about molecular dynamics in organic solids. 9 Recently, Michaelis et al. 10 and Blanc et al. 11 showed that dynamic nuclear polarization (DNP) can be used to drastically enhance the sensitivity of 17 O NMR spectroscopy. Although these two studies were carried out at moderate magnetic fields, it is certainly not impossible to overcome the technological hurdles in the near future so that DNP can be performed at ultrahigh magnetic fields. As a result of these new developments, it has become quite clear that the traditional difficulties hampering the development of 17 O NMR spectroscopy are gradually disappearing.
In the present work, we report 17 O-isotope labeling and solid-state 17 O NMR studies of two important pharmaceutical compounds: salicylic acid (SA) and o-acetylsalicylic acid (Aspirin); see Scheme 1. Between these two molecules, there are a total of seven oxygen sites that can be used as 17 O NMR probes. The medicinal use of SA can be traced back to the ancient Greek physician Hippocrates who prescribed extracts from willow bark for patients to relief pain and fever. 12 SA is now used in many modern drugs and health products. Aspirin is perhaps the best known "wonder drug". According to the Aspirin Foundation (http://www.aspirin-foundation.com/), approximately 35 000 t of Aspirin are produced and consumed annually worldwide, making it the most widely used drug of all times. In recent years, over 2000 scientific papers are published annually on the topic of Aspirin.
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The crystal structure of SA was first determined by Cochran in 1953. 14 Later, Sundaralingam and Jesen 15 reported a further refinement of the X-ray structure and Bacon and Jude 16 reported a crystal structure of SA determined by neutron diffraction. The crystal structure of Aspirin was first established in 1964. 17 Subsequently, higher quality X-ray and neutron structures were also reported. 18−20 For many decades, it was believed that crystalline Aspirin exists in only one polymorph (also known as form-I). In 2005, Zaworotko and co-workers 21 reported the preparation and crystal structure of a new Aspirin polymorph (form-II). Although there was debate about the initial data interpretation, it seems that the existence of Aspirin form-II polymorph has now been firmly established. 22−24 Similar to many carboxylic acids, SA and Aspirin molecules form centrosymmetric hydrogen bonded dimers in the crystal lattice, as illustrated in Figure 1 . In each dimer, the O···O separation is approximately 2.6 Å, corresponding to a mediumstrength hydrogen bond. A particularly interesting phenomenon in this kind of carboxylic acid dimers is concerned with the proton dynamics involving a concerted double proton transfer across two symmetry-related hydrogen bonds. In general, this proton transfer process is associated with a double-well potential. As the proton movement between the two potential minima is often less than 0.6 Å, translational quantum tunneling may become important. This is particularly true when the double-well potential is nearly symmetrical. In the solid state, however, crystal packing often introduces an energy asymmetry between the two minima of the potential curve. The present work was carried out with the following objectives in mind. First, we investigate the most efficient synthetic routes for introducing 17 O isotope into each of the oxygen sites in SA and Aspirin. Second, we fully characterize the 17 O QC and CS tensors for all oxygen sites in these two compounds. Third, we examine the effect of proton dynamics on the 17 In a dry, nitrogenflushed pressure tube were placed 8-hydroxyquinoline (180 mg), copper(I) iodide (140 mg), 2-iodobenzoic acid (1.5 g), and potassium tert-butoxide (2.68 g). The tube was capped with a rubber septum. To the mixture were added, via syringe, tertbutanol (3 mL) and anhydrous DMSO (6 mL). A flow of N 2 was passed through the mixture for 2 min, followed by addition of 20% 17 O-enriched water (660 mg). After replacing the septum with a pressure cap, the mixture was stirred in an oil bath at 100 ± 5°C for 44 h. After cooling down to room temperature, the mixture was acidified with concentrated HCl (1 mL) to pH 3−4. Insoluble materials were removed by filtration. The filtrate was extracted with ethyl acetate (6 × 20 mL). The organic extract was washed with 0.1 M HCl (15 mL), water (15 mL), and brine (2 × 10 mL) and then decolorized with active carbon. After solvent removal with a rotary evaporator, the solid residue was recrystallized from water (10 mL), giving the title compound as a white crystalline solid (415 mg, yield 50%): The liquid-state 17 Salicylic acid (278 mg) was dissolved in anhydrous THF (10 mL) and pyridine (0.6 mL). The flask was capped with a rubber septum, followed by addition of acetyl chloride (0.6 mL). The mixture was stirred at room temperature for 20 min. After solvent removal with a rotary evaporator at 20°C, the residual material was treated with cold water (15 mL) and the mixture was stirred in an ice−water bath for 2 h. The solid material was collected by filtration, washed with cold water (3 × 3 mL), and dried under a vacuum, giving the title compound as a white powder (204 O]Salicylic acid (280 mg) was dissolved in pyridine (0.8 mL) in a flask capped with a rubber septum and cooled in an ice−water bath. To the cold solution was added acetyl chloride (0.25 mL), and the mixture was kept in the ice−water bath (with occasional shaking) for 50 min. After addition of anhydrous THF (1 mL), the mixture was kept in the ice−water bath for another 25 min, followed by addition of cold water (10 mL). The cold mixture was then acidified with a concentrated HCl(aq) solution to pH 1−2 (approximately 0.45 mL of HCl) and was stirred in the ice− water bath for 1 h. Solid material was collected, washed with cold water (3 × 3 mL), and dried under a vacuum, producing the title compound as a white solid (230 mg): 17 O NMR (67.7 MHz, δ = 196.6 ppm with respect to the signal of liquid water). The 17 O enrichment level in the compound is the same as that in [3- 17 O]salicylic acid, ca. 20%. Preparation of [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] O]Aspirin. In a 25 mL round-bottom flask equipped with a rubber septum was first added acetyl chloride (0.36 mL) and then 40% 17 O-eniched water (90 μL) via a syringe. A needle was inserted into the flask for gas release. The mixture was kept at room temperature for 10 min with occasional shaking. Anhydrous THF (3 mL) was added into the flask through a syringe, and the mixture was kept at room temperature for 10 min. To the solution was added thionyl chloride (0.36 mL), and the mixture was heated briefly with a hot gun to lukewarm and then left at room temperature for 1 h. The flask was cooled in an ice−water bath for 10 min, followed by addition of salicylic acid (420 mg) in anhydrous pyridine (1 mL) via a syringe. The mixture was kept in the ice−water bath for 1 h, and then, the solvent was removed on a rotary evaporator at 20°C (for about 20 min.). To the residual material was added cold water (15 mL). The mixture was cooled in an ice−water bath and acidified with a concentrated HCl(aq) solution to pH 1−2. The mixture was stirred in the cold bath for 20 min. The solid material was collected, washed with cold water (3 × 3 mL), and dried under a vacuum, giving the title compound as a white powder: 17 17 O NMR spectra were obtained at 14.0 T (Queen's University, Kingston, Ontario, Canada) and 21.1 T (National UltrahighField NMR Facility for Solids, Ottawa, Ontario, Canada). At 14.0 T, the MAS experiments were performed on a Bruker 4 mm H/X MAS probe with a sample spinning of 14.5 kHz. 17 O MAS NMR spectra at 21.1 T were acquired using a 3.2 mm H/ X MAS Bruker probe with a sample spinning frequency of 22 kHz. It is important to point out that, under this MAS spinning speed, the actual temperature of the sample was determined to be about 20 K higher than the room temperature, 298 K, due to frictional heating of the sample. A rotor-synchronized 90°-delay-180°-echo pulse sequence was used with a CT-selective 90°pulse length of 3 μs. Typically, relaxation delays of 2−5 s were found sufficient for most samples, and the number of scans varied from 2048 to 4096. The proton decoupling was normally not used when acquiring 17 17 O NMR spectra were acquired with a home-built 5 mm H/X solenoid probe using a 90°-delay-90°-echo pulse sequence to avoid powder line shape distortions. To minimize the unwanted 17 O background signals, the powder samples were packed in 5 mm o.d. Teflon tubes (Norell). The high power proton decoupling (ca. 70 kHz) was used to acquire all static spectra. The CT-selective π/2 pulse length was 2 μs, and the echo delay was 50 μs. Typically, 4096 scans were accumulated for each spectrum using a relaxation delay of 2−5 s. 1 H MAS NMR spectra were acquired at 21.1 T using a 1.3 mm H/X MAS Bruker probe with a sample spinning of 62.5 kHz. A rotor-synchronized 90°-delay-90°-echo pulse sequence was used with a 1 H 90°pulse length of 2 μs. The
The Journal of Physical Chemistry B residual proton background signal was further removed by recording a background spectrum using a rotor containing NaCl(s) and then subtracting it out from the actual spectrum. The relaxation delay was 60 s, and the number of scans was either 64 or 128. Solid-state 13 C NMR spectra were recorded at 14.0 T under the cross-polarization (CP), MAS, and highpower 1 H decoupling conditions. Variable-temperature (VT) 17 O MAS NMR spectra were obtained at 21.1 T (National High Magnetic Field Laboratory, Tallahassee, FL, USA) with a 900 MHz Bruker Avance console and a 3.2 mm home-built MAS H/X transmission line probe. Sample temperatures under the 20 kHz MAS condition were calibrated using solid Pb(NO 3 ) 2 , and the actual temperature range of the VT MAS probe was 360−146 K. Spectral analyses were performed with the DMfit software. 44 All 17 O chemical shifts were referenced to the signal of a liquid water sample, and 1 H and 13 C chemical shifts were referenced to the signals of TMS.
2.3. Plane-Wave DFT Calculations. All plane-wave DFT calculations were performed with the CASTEP software 45 and the Materials Studio 4.4 program (Accelrys) running on a Linux server with two 2.66 GHz processing cores and 8 GB of RAM. Perdew, Burke, and Ernzerhof (PBE) functionals were used with a plane wave basis set cutoff of 610 eV and a 3 × 1 × 2 Monkhorst−Pack k-space grid. The most recent crystal structures of SA (CCDC code: 871047) 46 and Aspirin (CCDC code: 610952) 22 were used as initial structures, and then, a full optimization was performed for each structure while keeping the unit cell parameters at their experimental values. Some key bond lengths from various X-ray, neutron, and CASTEP-optimized crystal structures of SA and Aspirin are compared in the Supporting Information. In general, the fully CASTEP-optimized structures have bond lengths and angles that are within the experimental uncertainties of the neutron diffraction structures. Magnetic shielding tensors and electric field gradient (EFG) tensors were then calculated for all nuclei with the gauge-including projector augmented wave (GIPAW) 47 Figure  2 shows the 17 O MAS NMR spectra obtained for the five compounds of site-specifically 17 O-labeled SA and Aspirin at 14.0 and 21.1 T. One can see clearly that the spectra obtained at 21.1 T are generally of higher quality than those obtained at 14.0 T. We were able to simulate both sets of experimental MAS spectra and extract accurate δ iso , C Q , and η Q values for each oxygen site. These parameters were then fixed in the simulations of static spectra, which allowed not only the tensor components to be measured but also the relative orientation between the CS and QC tensors. The general procedure of this kind of spectral analysis was outlined in our previous publications. 50, 51 The experimental static 17 O NMR spectra obtained at 21.1 T for SA and Aspirin are shown in Figure 3 . Static 17 O NMR spectra were also recorded at 14.0 T for the same set of SA and Aspirin samples (given in the Supporting Information 27 for an ester, methyl-p-anisate. However, we also note that the 17 O chemical shifts of O 3 and O 4 of Aspirin are considerably higher (more deshielded) than those in methyl-p-anisate. This discrepancy can be attributed to the structural difference between the two compounds. In particular, a Uncertainties in the experimental tensor parameters were estimated by comparing the quality of fit between observed and simulated spectra: δ iso ± 1 ppm, δ ii (i = 1, 2, 3) ± 10 ppm, C Q ± 0.05 MHz, η Q ± 0.05, Euler angles ±10°. b Signs in the experimental C Q values were assumed to be the same as those from the computations. 17−20 whereas the ester plane in methyl-p-anisate is very likely to be coplanar with the phenyl plane with the CO bond being part of a conjugated system. 55 It has long been known that the 17 O chemical shifts of both oxygens in aromatic esters increase with the torsion angle between the ester sp 2 plane and the aromatic ring. 56 Of course, this apparent correlation is not due to the torsion angle per se. Rather, as we have previously explained the parallel trend in 13 C NMR, 57 the origin of this correlation is due to the fact that the π* molecular orbital that is linked to the paramagnetic shielding contribution through n → π* magnetic mixing becomes more localized on the ester functional group when the torsion angle is increased. The carbonyl type oxygen, O 4 , of Aspirin exhibits a very large chemical shift anisotropy, δ 11 − δ 33 = 573 ppm. Compared with other carbonyl compounds, the 17 O chemical shift anisotropy found for the carbonyl oxygen in the ester group follows the known trend: aldehyde/ketone > ester ≈ amide > carboxylic acid. 4 While the ether type oxygen, O 3 , has a relatively large |C Q | value (9.50 MHz), it exhibits a relatively small chemical shift anisotropy (δ 11 − δ 33 = 244 ppm). These appear to be the first set of 17 O CS tensors reported for an ester functional group.
3.2. 17 O NMR Data Analysis for Carboxylic Acid Dimers. As mentioned earlier, SA and Aspirin form cyclic hydrogen bonded dimers in the crystal lattice; see Figure 4 . The concerted double proton transfer in this type of carboxylic acid 58−68 In general, the double proton transfer occurs on a time scale that is much faster than the NMR Larmor frequency (e.g., 10 8 Hz for 17 O at 21.1 T) even at very low temperatures. 25 Therefore, all experimental NMR tensors in a carboxylic acid dimer are averaged between the corresponding "rigid" tensors found in configurations A and B, as defined in Figure 4 . In general, the two configurations have different energies due to either crystal packing or some intramolecular interactions. As a result, the averaging effect on the two oxygen atoms would lead to two different 17 where P A and P B are the probabilities of finding the system in configurations A and B, respectively. If the energy asymmetry of the double-well potential curve between configurations A and B is defined as ΔE, we have
where R is the gas constant and T is the absolute temperature of the system. It is important to recognize that the averaging in the above equations occurs between tensor quantities. This can be readily done by taking a weighted average of individual tensor matrix elements in a common frame of reference followed by diagonalization of the averaged tensor to yield the principal components. Since 17 O NMR tensors may be different in the two configurations, it is necessary to compute them for both configurations. For configuration B, we first manually moved the two protons and then performed full geometry optimization using CASTEP. Although all atoms were relaxed during the geometry optimization, the two protons did not return to their original positions found in configuration A, suggesting that configuration B is a true local minimum. After establishing the proper crystal structures for configurations A and B, we calculate the 17 O QC and CS tensors for both configurations A and B for SA and Aspirin; see Table 2 . For comparison, we also listed in Table 2 the computational results for Aspirin (form-II). The computed 17 O NMR tensor orientations for O 1 and O 2 in SA and Aspirin are illustrated in Figure 5 . It is clear that both 17 O QC and CS tensors change their orientations as a result of the double proton transfer. Therefore, it is important to treat the whole tensor in the averaging process. Now we can determine the value of P A by using eqs 1 and 2. As seen from Figure 6 , the best-fit P A values for Aspirin are 0.74 ± 0.02 and 0.82 ± 0.02 from analyses of 17 O QC and CS tensor components, respectively. Thus, we report a mean value of P A for Aspirin, 0.78 ± 0.04. For SA, it is more difficult to estimate the best-fit P A , as it is very close to 1. Nonetheless, combining the 17 O QC and CS data shown in Figure 6 , we estimate a mean value of P A for SA, 0.98 ± 0.02. These results suggest that the SA dimer exhibits a much larger energy asymmetry than does the Aspirin dimer. Our P A value for Aspirin is in excellent agreement with that found from an analysis of 17 O NQR data, P A = 0.77 at 291 K. 33 For SA, there does not appear to be any report on P A in the literature.
To further confirm the above data analyses and, more importantly, to obtain accurate values of ΔE, we recorded VT 17 O MAS spectra for both [ O 2 ]Asiprin are highly temperature dependent. In particular, as the temperature is increased, the two peaks observed for Aspirin move gradually toward each other. In addition, the 17 O QC parameters (line shapes) change considerably as a function of temperature. For example, the values of η Q for the two peaks are 0.35 and 0.05 at 146 K, and they change to 0.80 and 0.25 at 360 K. For both sites, the values of C Q also decrease by approximately 20% as the temperature is increased from 146 to 360 K. Using the averaging procedure described in eqs 1−3, together with the CASTEP data shown in Table 2 , we were able to fit the observed temperature dependent isotropic 17 O chemical shifts, as shown in Figure  8 , and extract an accurate value of ΔE for Aspirin, 3.0 ± 0.5 kJ/ mol. The isotropic 17 O chemical shifts for the two sites change more than 25 ppm between 146 and 360 K.
For SA, as no obvious temperature dependence was observed, only a lower limit for ΔE can be estimated, ΔE > 10 kJ/mol, on the basis of the aforementioned best-fit P A value of 0.98 at 298 K. These experimental data on the energy asymmetry are in good agreement with the results from our plane-wave DFT computations: ΔE = 17.8 kJ/mol for SA and ΔE = 3.7 kJ/mol for Aspirin. Previously, ΔE values for carboxylic acid dimers were found to lie in a range from ∼0.5 kJ/mol in benzoic acid 58 to 3.4 kJ/mol in malonic acid 69 to 5.9 kJ/mol in β-oxalic acid. 33 Thus, while the energy asymmetry found in Aspirin appears to be in the middle of the range, the energy asymmetry in SA is so large that the proton dynamics is significantly hindered. It is particularly interesting to further compare SA with other related derivatives of benzoic acid. For 4-substituted benzoic acids, the ΔE values are all approximately 1 kJ/mol. 70, 71 For 2-nitrobenzoic acid, the value of ΔE increases to 5.8 kJ/mol. 72 It is clear that the very large ΔE value in SA is due to the formation of an intramolecular O 3  H···O 2 hydrogen bond that strongly favors configuration A, in which CO 2 and O 3 H are on the same side of the molecule; see Figure 1 . Our observations of very different ΔE values in SA and Aspirin are also consistent with the neutron diffraction data. More specifically, Bacon and Jude 16 reported that the acid proton in SA exhibits a normal thermal B factor (3.78 Å 2 ). In contrast, Wilson 19, 20 observed significant elongation of the thermal ellipsoid for the acid proton in Aspirin above 200 K, which can be modeled by proton dynamics within an asymmetric double-well potential.
3.3. Comparison between Experimental and Computed NMR Parameters. After establishing a proper averaging model for data analysis in the previous section, we now can quantitatively compare the experimental and computed 17 O NMR tensors for all oxygen sites found in SA and Aspirin. For completeness, we also recorded 13 C CP/MAS NMR spectra (given in the Supporting Information) and 1 H very fast MAS NMR spectra (shown in Figure 9 ) for SA and Aspirin. It is important to point out that the 13 C CP/MAS NMR spectra were also used to confirm the structural polymorph of each solid sample. This step ensures that a comparison between experimental and computed NMR parameters is meaningful. The experimental solid-state 13 C and 1 H chemical shifts for SA and Aspirin are given in Table 3 . Here it is worth noting that all NMR parameters computed for the two Aspirin polymorphs (form-I and form-II) are very similar. This finding is not unexpected, as the crystal structures of the two polymorphs exhibit only very subtle differences, as explained previously. 21−23 Interestingly, our plane-wave DFT computations suggest that the largest detectable difference between form-I and form-II occurs on the 13 C chemical shift for the methyl group, C9, with a chemical shift difference of 1.78 ppm between the two polymorphs. This result is consistent with a previous report where the 13 C CP/MAS spectrum of a lyophilized Aspirin sample shows splitting in the methyl signal. 73 Perhaps this spectral feature could be used as an "NMR spectral signature" for differentiating between the two Aspirin polymorphs. Now that we have obtained solid-state NMR parameters for all magnetic nuclei in SA and Aspirin, we can evaluate the accuracy of the computational results for these nuclei simultaneously. As seen from Figure 10 , the overall agreement between experimental and computed results is excellent. It should be noted that, in Figure 10a and b, the computed 17 O NMR tensor components for O 1 and O 2 of Aspirin are the "averaged" values as outlined in the previous section rather than the "rigid" values shown in Table 2 . For the 17 O QC and CS tensor components, the root-mean-squared (RMS) errors are approximately 0.4 MHz and 20 ppm, respectively. We should note that the experimental uncertainties in experimental tensor components are considerably larger than those for the isotropic values. For the isotropic 13 C and 1 H chemical shifts, the RMS errors are 7.9 and 1.5 ppm, respectively. However, these RMS errors are reduced to 2.4 and 0.9 ppm after the nonunitary slopes are corrected. 74 Recently, Esrafili and co-workers 75−77 computed NMR parameters in SA and Aspirin using a molecular cluster approach. A comparison of our results and theirs clearly suggests that the plane-wave DFT is a far better method than the cluster approach for predicting solid-state 31 reported that C Q = 173.1 kHz and η Q = 0.143 for the carboxylic deuteron at 291 K, which can be compared with our plane-wave DFT results: C Q = 141.6 kHz and η Q = 0.167. In general, we found a reasonable agreement between experimental and computed 2 H quadrupole parameters for SA and Aspirin.
SUMMARY
We have reported synthesis and solid-state 17 O NMR results for five site-specifically 17 O-labeled samples of SA and Aspirin. Carefully designed synthetic procedures ensured highly selective 17 O-labeling at the desired oxygen sites in SA and Aspirin, and excellent yields were achieved in most cases. Highquality solid-state 17 O NMR spectra obtained at two magnetic fields allowed us to extract a complete set of reliable 17 O QC and CS tensor parameters in these important pharmaceutical compounds. We demonstrated that it is important to take into consideration the averaging effect due to concerted double proton transfer in carboxylic acid dimers in order to compare experimental and computed 17 O NMR tensors for carboxylic acid functional groups. Further, we showed that a careful analysis of variable temperature 17 O NMR spectra of Aspirin provided an accurate measure of the energy asymmetry between the two energy minima in the double-well potential. Using experimental NMR parameters observed for all magnetic nuclei ( 17 O, 13 C, and 1 H) in SA and Aspirin, we found that the plane-wave DFT computations are highly accurate for predicting NMR parameters for these light elements in welldefined crystalline organic solids. It is possible to extend the present study to other pharmaceutical materials including cocrystals. Now that we have successfully made site-specifically 17 O-labeled SA and Aspirin, it is also possible to use 17 O NMR to probe the binding of these molecules to biological macromolecules. Research in this direction is underway in our laboratory. 
